Gastro-oesophageal reflux: Clinical profiles and outcome

Objectives: To assess the clinical features, investigations and outcome of 69 children (40 males, 29 females) with gastro‐oesophageal reflux (GOER) referred to a tertiary referral centre in paediatric gastroenterology. Methods: A study of all patients with significant GOER seen at the Paediatric Gas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of paediatrics and child health 1999-12, Vol.35 (6), p.568-571
Hauptverfasser: Lee, WS, Beattie, RM, Meadows, N, Walker-Smith, JA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 571
container_issue 6
container_start_page 568
container_title Journal of paediatrics and child health
container_volume 35
creator Lee, WS
Beattie, RM
Meadows, N
Walker-Smith, JA
description Objectives: To assess the clinical features, investigations and outcome of 69 children (40 males, 29 females) with gastro‐oesophageal reflux (GOER) referred to a tertiary referral centre in paediatric gastroenterology. Methods: A study of all patients with significant GOER seen at the Paediatric Gastroenterology Unit, Queen Elizabeth Hospital for Children, Hackney Road, London, between December 1994 and August 1995. Results: The median age at referral was 16 months. Presenting symptoms were recurrent vomiting (72%), epigastric and abdominal pain (36%), feeding difficulties (29%), failure to thrive (28%) and irritability (19%). Continuous 24‐h lower oesophageal pH studies performed in 57 children showed 20 (35%) had a reflux index of between 10% to 20%, 14 (25%) had a index > 20%, and six (11%) had a postprandial reflux index > 10%. Reflux was shown in 38 (62%) of 62 children who underwent barium studies. None had significant anatomical abnormalities, but in the 22 children who had a negative barium studies, six had severe reflux (reflux index > 20%). Upper gastrointestinal endoscopy performed in 47 children showed reflux oesophagitis in 29 (62%), oesophageal ulceration in three, and Barrett’s oesophagus in one. All of the children were treated with standard medical therapy. Sixty‐six per cent were able to discontinue medication within 12 months and remained well. Four children (6%) required Nissen’s fundoplication for failure to respond to medical therapy. Conclusions: Most infants with GOER have an uncomplicated course. False negative results were noted in both pH monitoring and barium meal. Up to 80% of children, with therapy, will improve within 12 months.
doi_str_mv 10.1046/j.1440-1754.1999.00442.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69404592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69404592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5282-58b6ff6aef33c6caa02b6585f1c41bb81e1f63b06850f9c123ee36e8ab9591fe3</originalsourceid><addsrcrecordid>eNqNkU1PGzEQhi1EBZTyF9AeELfdjj9jIy4QkbRVCkiAOFpeM4YNm2xYZ9Xw7-uwEeVWTh7Zz-sZPyYko1BQEOr7tKBCQE4HUhTUGFMACMGK1RbZez_YTjVwkQtNYZd8jXEKAExKvUN2KSgujJZ7RI9dXLZN3mBsFk_uEV2dtRjqbnWSDetqXvm0sWibUNUYMzd_yJpu6ZsZfiNfgqsjHmzWfXI3urgd_sgnV-Ofw7NJ7iXTLJe6VCEoh4Fzr7xzwEoltQzUC1qWmiINipegtIRgPGUckSvUrjTS0IB8nxz396YhXjqMSzurose6dnNsumiVESCkYf8F5UCBZm-g7kHfNjGmx9pFW81c-2op2LVeO7Vri3Zt0a712je9dpWih5seXTnDhw_B3mcCjjaAi8lcaN3cV_Efx6hKn5Cw0x77k7S-frq__XU9TEWK5328iktcvcdd-2zVgA-kvb8c29FvMToXkxs74n8BYFajvQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57608292</pqid></control><display><type>article</type><title>Gastro-oesophageal reflux: Clinical profiles and outcome</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lee, WS ; Beattie, RM ; Meadows, N ; Walker-Smith, JA</creator><creatorcontrib>Lee, WS ; Beattie, RM ; Meadows, N ; Walker-Smith, JA</creatorcontrib><description>Objectives: To assess the clinical features, investigations and outcome of 69 children (40 males, 29 females) with gastro‐oesophageal reflux (GOER) referred to a tertiary referral centre in paediatric gastroenterology. Methods: A study of all patients with significant GOER seen at the Paediatric Gastroenterology Unit, Queen Elizabeth Hospital for Children, Hackney Road, London, between December 1994 and August 1995. Results: The median age at referral was 16 months. Presenting symptoms were recurrent vomiting (72%), epigastric and abdominal pain (36%), feeding difficulties (29%), failure to thrive (28%) and irritability (19%). Continuous 24‐h lower oesophageal pH studies performed in 57 children showed 20 (35%) had a reflux index of between 10% to 20%, 14 (25%) had a index &gt; 20%, and six (11%) had a postprandial reflux index &gt; 10%. Reflux was shown in 38 (62%) of 62 children who underwent barium studies. None had significant anatomical abnormalities, but in the 22 children who had a negative barium studies, six had severe reflux (reflux index &gt; 20%). Upper gastrointestinal endoscopy performed in 47 children showed reflux oesophagitis in 29 (62%), oesophageal ulceration in three, and Barrett’s oesophagus in one. All of the children were treated with standard medical therapy. Sixty‐six per cent were able to discontinue medication within 12 months and remained well. Four children (6%) required Nissen’s fundoplication for failure to respond to medical therapy. Conclusions: Most infants with GOER have an uncomplicated course. False negative results were noted in both pH monitoring and barium meal. Up to 80% of children, with therapy, will improve within 12 months.</description><identifier>ISSN: 1034-4810</identifier><identifier>EISSN: 1440-1754</identifier><identifier>DOI: 10.1046/j.1440-1754.1999.00442.x</identifier><identifier>PMID: 10634985</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Science Pty</publisher><subject>Adolescent ; Biological and medical sciences ; Child ; Child, Preschool ; Children ; Cisapride - therapeutic use ; Esophagoscopy ; Female ; Fundoplication ; Gastro-oesophageal disease ; gastro-oesophageal reflux ; Gastroenterology. Liver. Pancreas. Abdomen ; Gastroesophageal Reflux - drug therapy ; Gastroesophageal Reflux - physiopathology ; Gastroesophageal Reflux - surgery ; Gastrointestinal Agents - therapeutic use ; Histamine H2 Antagonists - therapeutic use ; Humans ; Infant ; Infant, Newborn ; Male ; Malformations ; Medical sciences ; Omeprazole - therapeutic use ; Outcomes ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Treatment Outcome</subject><ispartof>Journal of paediatrics and child health, 1999-12, Vol.35 (6), p.568-571</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5282-58b6ff6aef33c6caa02b6585f1c41bb81e1f63b06850f9c123ee36e8ab9591fe3</citedby><cites>FETCH-LOGICAL-c5282-58b6ff6aef33c6caa02b6585f1c41bb81e1f63b06850f9c123ee36e8ab9591fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1440-1754.1999.00442.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1440-1754.1999.00442.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,30977,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1216002$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10634985$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, WS</creatorcontrib><creatorcontrib>Beattie, RM</creatorcontrib><creatorcontrib>Meadows, N</creatorcontrib><creatorcontrib>Walker-Smith, JA</creatorcontrib><title>Gastro-oesophageal reflux: Clinical profiles and outcome</title><title>Journal of paediatrics and child health</title><addtitle>J Paediatr Child Health</addtitle><description>Objectives: To assess the clinical features, investigations and outcome of 69 children (40 males, 29 females) with gastro‐oesophageal reflux (GOER) referred to a tertiary referral centre in paediatric gastroenterology. Methods: A study of all patients with significant GOER seen at the Paediatric Gastroenterology Unit, Queen Elizabeth Hospital for Children, Hackney Road, London, between December 1994 and August 1995. Results: The median age at referral was 16 months. Presenting symptoms were recurrent vomiting (72%), epigastric and abdominal pain (36%), feeding difficulties (29%), failure to thrive (28%) and irritability (19%). Continuous 24‐h lower oesophageal pH studies performed in 57 children showed 20 (35%) had a reflux index of between 10% to 20%, 14 (25%) had a index &gt; 20%, and six (11%) had a postprandial reflux index &gt; 10%. Reflux was shown in 38 (62%) of 62 children who underwent barium studies. None had significant anatomical abnormalities, but in the 22 children who had a negative barium studies, six had severe reflux (reflux index &gt; 20%). Upper gastrointestinal endoscopy performed in 47 children showed reflux oesophagitis in 29 (62%), oesophageal ulceration in three, and Barrett’s oesophagus in one. All of the children were treated with standard medical therapy. Sixty‐six per cent were able to discontinue medication within 12 months and remained well. Four children (6%) required Nissen’s fundoplication for failure to respond to medical therapy. Conclusions: Most infants with GOER have an uncomplicated course. False negative results were noted in both pH monitoring and barium meal. Up to 80% of children, with therapy, will improve within 12 months.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Cisapride - therapeutic use</subject><subject>Esophagoscopy</subject><subject>Female</subject><subject>Fundoplication</subject><subject>Gastro-oesophageal disease</subject><subject>gastro-oesophageal reflux</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gastroesophageal Reflux - drug therapy</subject><subject>Gastroesophageal Reflux - physiopathology</subject><subject>Gastroesophageal Reflux - surgery</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Histamine H2 Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Malformations</subject><subject>Medical sciences</subject><subject>Omeprazole - therapeutic use</subject><subject>Outcomes</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Treatment Outcome</subject><issn>1034-4810</issn><issn>1440-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkU1PGzEQhi1EBZTyF9AeELfdjj9jIy4QkbRVCkiAOFpeM4YNm2xYZ9Xw7-uwEeVWTh7Zz-sZPyYko1BQEOr7tKBCQE4HUhTUGFMACMGK1RbZez_YTjVwkQtNYZd8jXEKAExKvUN2KSgujJZ7RI9dXLZN3mBsFk_uEV2dtRjqbnWSDetqXvm0sWibUNUYMzd_yJpu6ZsZfiNfgqsjHmzWfXI3urgd_sgnV-Ofw7NJ7iXTLJe6VCEoh4Fzr7xzwEoltQzUC1qWmiINipegtIRgPGUckSvUrjTS0IB8nxz396YhXjqMSzurose6dnNsumiVESCkYf8F5UCBZm-g7kHfNjGmx9pFW81c-2op2LVeO7Vri3Zt0a712je9dpWih5seXTnDhw_B3mcCjjaAi8lcaN3cV_Efx6hKn5Cw0x77k7S-frq__XU9TEWK5328iktcvcdd-2zVgA-kvb8c29FvMToXkxs74n8BYFajvQ</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>Lee, WS</creator><creator>Beattie, RM</creator><creator>Meadows, N</creator><creator>Walker-Smith, JA</creator><general>Blackwell Science Pty</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7X8</scope></search><sort><creationdate>199912</creationdate><title>Gastro-oesophageal reflux: Clinical profiles and outcome</title><author>Lee, WS ; Beattie, RM ; Meadows, N ; Walker-Smith, JA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5282-58b6ff6aef33c6caa02b6585f1c41bb81e1f63b06850f9c123ee36e8ab9591fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Cisapride - therapeutic use</topic><topic>Esophagoscopy</topic><topic>Female</topic><topic>Fundoplication</topic><topic>Gastro-oesophageal disease</topic><topic>gastro-oesophageal reflux</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gastroesophageal Reflux - drug therapy</topic><topic>Gastroesophageal Reflux - physiopathology</topic><topic>Gastroesophageal Reflux - surgery</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Histamine H2 Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Malformations</topic><topic>Medical sciences</topic><topic>Omeprazole - therapeutic use</topic><topic>Outcomes</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, WS</creatorcontrib><creatorcontrib>Beattie, RM</creatorcontrib><creatorcontrib>Meadows, N</creatorcontrib><creatorcontrib>Walker-Smith, JA</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of paediatrics and child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, WS</au><au>Beattie, RM</au><au>Meadows, N</au><au>Walker-Smith, JA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastro-oesophageal reflux: Clinical profiles and outcome</atitle><jtitle>Journal of paediatrics and child health</jtitle><addtitle>J Paediatr Child Health</addtitle><date>1999-12</date><risdate>1999</risdate><volume>35</volume><issue>6</issue><spage>568</spage><epage>571</epage><pages>568-571</pages><issn>1034-4810</issn><eissn>1440-1754</eissn><abstract>Objectives: To assess the clinical features, investigations and outcome of 69 children (40 males, 29 females) with gastro‐oesophageal reflux (GOER) referred to a tertiary referral centre in paediatric gastroenterology. Methods: A study of all patients with significant GOER seen at the Paediatric Gastroenterology Unit, Queen Elizabeth Hospital for Children, Hackney Road, London, between December 1994 and August 1995. Results: The median age at referral was 16 months. Presenting symptoms were recurrent vomiting (72%), epigastric and abdominal pain (36%), feeding difficulties (29%), failure to thrive (28%) and irritability (19%). Continuous 24‐h lower oesophageal pH studies performed in 57 children showed 20 (35%) had a reflux index of between 10% to 20%, 14 (25%) had a index &gt; 20%, and six (11%) had a postprandial reflux index &gt; 10%. Reflux was shown in 38 (62%) of 62 children who underwent barium studies. None had significant anatomical abnormalities, but in the 22 children who had a negative barium studies, six had severe reflux (reflux index &gt; 20%). Upper gastrointestinal endoscopy performed in 47 children showed reflux oesophagitis in 29 (62%), oesophageal ulceration in three, and Barrett’s oesophagus in one. All of the children were treated with standard medical therapy. Sixty‐six per cent were able to discontinue medication within 12 months and remained well. Four children (6%) required Nissen’s fundoplication for failure to respond to medical therapy. Conclusions: Most infants with GOER have an uncomplicated course. False negative results were noted in both pH monitoring and barium meal. Up to 80% of children, with therapy, will improve within 12 months.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Science Pty</pub><pmid>10634985</pmid><doi>10.1046/j.1440-1754.1999.00442.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1034-4810
ispartof Journal of paediatrics and child health, 1999-12, Vol.35 (6), p.568-571
issn 1034-4810
1440-1754
language eng
recordid cdi_proquest_miscellaneous_69404592
source Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Biological and medical sciences
Child
Child, Preschool
Children
Cisapride - therapeutic use
Esophagoscopy
Female
Fundoplication
Gastro-oesophageal disease
gastro-oesophageal reflux
Gastroenterology. Liver. Pancreas. Abdomen
Gastroesophageal Reflux - drug therapy
Gastroesophageal Reflux - physiopathology
Gastroesophageal Reflux - surgery
Gastrointestinal Agents - therapeutic use
Histamine H2 Antagonists - therapeutic use
Humans
Infant
Infant, Newborn
Male
Malformations
Medical sciences
Omeprazole - therapeutic use
Outcomes
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Treatment Outcome
title Gastro-oesophageal reflux: Clinical profiles and outcome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A51%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastro-oesophageal%20reflux:%20Clinical%20profiles%20and%20outcome&rft.jtitle=Journal%20of%20paediatrics%20and%20child%20health&rft.au=Lee,%20WS&rft.date=1999-12&rft.volume=35&rft.issue=6&rft.spage=568&rft.epage=571&rft.pages=568-571&rft.issn=1034-4810&rft.eissn=1440-1754&rft_id=info:doi/10.1046/j.1440-1754.1999.00442.x&rft_dat=%3Cproquest_cross%3E69404592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=57608292&rft_id=info:pmid/10634985&rfr_iscdi=true